This study also illustrates the difficulties of predicting the effect of rapalogs on Akt as only 50% of the patients had increased Akt phosphorylation in the tumor following rapamycin treatment although all patients suffered from glioblastoma. The gene discussed is AKT1; the disease is neoplasm.